The company says there's a need for opioid pain medicines that don't require swallowing, because some patients have difficulty taking oral medication and may not have access to IV opioids. The FDA had earlier flagged two safety concerns.
Read more: https://www.webmd.com/pain-management/news/20181018/fda-panel-oks-stronger-opioid-despite-concerns?source=Snapzu
No comments:
Post a Comment